Short Interest in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Increases By 20.0%

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was the recipient of a large increase in short interest during the month of January. As of January 30th, there was short interest totaling 26,360,014 shares, an increase of 20.0% from the January 15th total of 21,965,300 shares. Currently, 29.2% of the shares of the company are short sold. Based on an average daily volume of 4,378,165 shares, the days-to-cover ratio is presently 6.0 days. Based on an average daily volume of 4,378,165 shares, the days-to-cover ratio is presently 6.0 days. Currently, 29.2% of the shares of the company are short sold.

Institutional Trading of Acadia Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Goldman Sachs Group Inc. boosted its stake in Acadia Healthcare by 417.8% in the 4th quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after purchasing an additional 3,815,471 shares during the period. Jefferies Financial Group Inc. purchased a new stake in shares of Acadia Healthcare in the fourth quarter valued at $47,960,000. Abrams Bison Investments LLC boosted its position in shares of Acadia Healthcare by 96.7% in the second quarter. Abrams Bison Investments LLC now owns 3,580,000 shares of the company’s stock worth $81,230,000 after buying an additional 1,760,000 shares during the period. Deerfield Management Company L.P. purchased a new position in shares of Acadia Healthcare during the third quarter valued at $29,440,000. Finally, Rubric Capital Management LP acquired a new position in Acadia Healthcare during the third quarter valued at $27,236,000.

Acadia Healthcare Trading Up 5.5%

Shares of Acadia Healthcare stock opened at $16.77 on Tuesday. The business has a fifty day simple moving average of $14.02 and a 200-day simple moving average of $18.63. Acadia Healthcare has a fifty-two week low of $11.43 and a fifty-two week high of $42.85. The firm has a market cap of $1.55 billion, a price-to-earnings ratio of 14.33, a price-to-earnings-growth ratio of 4.77 and a beta of 0.89. The company has a quick ratio of 1.44, a current ratio of 1.44 and a debt-to-equity ratio of 0.73.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on ACHC shares. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, January 21st. Royal Bank Of Canada cut their target price on Acadia Healthcare from $19.00 to $17.00 and set an “outperform” rating on the stock in a research note on Wednesday, January 14th. TD Cowen reiterated a “reduce” rating on shares of Acadia Healthcare in a research report on Friday, January 16th. Raymond James Financial set a $17.00 price target on Acadia Healthcare in a report on Wednesday, December 3rd. Finally, KeyCorp reduced their price objective on shares of Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating for the company in a report on Wednesday, December 3rd. Six investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $18.62.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.